Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted Therapy

被引：0
|
作者：
Francesco Massari
Vincenzo Di Nunno
Lidia Gatto
Matteo Santoni
Riccardo Schiavina
Laura Cosmai
Eugenio Brunocilla
Andrea Ardizzoni
Camillo Porta
机构：
[1] S.Orsola-Malpighi Hospital,Division of Oncology
[2] Oncology Unit,Department of Urology
[3] Macerata Hospital,undefined
[4] University of Bologna,undefined
[5] S.Orsola-Malpighi Hospital,undefined
[6] Onco-Nephrology Outpatients’ Clinic,undefined
[7] San Carlo Borromeo Hospital,undefined
[8] ASST Santi Paolo e Carlo,undefined
[9] University of Pavia and IRCCS San Matteo University Hospital,undefined
来源：
Targeted Oncology | 2018年 / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：705 / 714
页数：9
相关论文
共 50 条
  • [11] VALUE OF CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA DURING THE TARGETED THERAPY ERA
    You, Dalsan
    Jeong, In Gab
    Song, Cheryn
    Jung, Han
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    JOURNAL OF UROLOGY, 2010, 183 (04): : E641 - E641
  • [12] Cytoreductive nephrectomy for metastatic renal cell carcinoma: Is it still imperative in the era of targeted therapy?
    Pantuck, Allan J.
    Belldegrun, Arie S.
    Figlin, Robert A.
    CLINICAL CANCER RESEARCH, 2007, 13 (02) : 693S - 696S
  • [13] Cytoreductive Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma in the Targeted Therapy Era
    Uprety, Dipesh
    Bista, Amir
    Smith, Angela L.
    Vallatharasu, Yazhini
    Marinier, David E.
    ANTICANCER RESEARCH, 2018, 38 (05) : 3013 - 3018
  • [14] Prognostic value of cytoreductive nephrectomy combined with targeted therapy for metastatic renal cell carcinoma: a meta-analysis
    Xuwei Hong
    Fei Li
    Kaiqiang Tang
    Shiyu Pang
    Guangzheng Lin
    Shi Li
    Jiming Bao
    Wanlong Tan
    International Urology and Nephrology, 2016, 48 : 967 - 975
  • [15] Prognostic value of cytoreductive nephrectomy combined with targeted therapy for metastatic renal cell carcinoma: a meta-analysis
    Hong, Xuwei
    Li, Fei
    Tang, Kaiqiang
    Pang, Shiyu
    Lin, Guangzheng
    Li, Shi
    Bao, Jiming
    Tan, Wanlong
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (06) : 967 - 975
  • [16] Role of Cytoreductive Nephrectomy in the Era of Targeted Therapy for Renal Cell Carcinoma
    Crispen, Paul L.
    Blute, Michael L.
    CURRENT UROLOGY REPORTS, 2012, 13 (01) : 38 - 46
  • [17] Role of Cytoreductive Nephrectomy in the Era of Targeted Therapy for Renal Cell Carcinoma
    Paul L. Crispen
    Michael L. Blute
    Current Urology Reports, 2012, 13 : 38 - 46
  • [18] The role of cytoreductive nephrectomy for renal cell carcinoma in the era of targeted therapy
    Chowdhury, Simon
    Harper, Peter G.
    Choueiri, Toni K.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (12): : 698 - 699
  • [19] The role of cytoreductive nephrectomy for renal cell carcinoma in the era of targeted therapy
    Simon Chowdhury
    Peter G Harper
    Toni K Choueiri
    Nature Clinical Practice Oncology, 2008, 5 : 698 - 699
  • [20] Does CARMENA mark the end of cytoreductive nephrectomy for metastatic renal cell carcinoma?
    Chang, Steven L.
    Choueiri, Toni K.
    Harshman, Lauren C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (08) : 525 - 528
12345